Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06127043
PHASE2

A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)

Sponsor: AnaptysBio, Inc.

View on ClinicalTrials.gov

Summary

ROSETTA STUDY: This study will evaluate the safety, tolerability, and efficacy of Rosnilimab in subjects with moderate to severe ulcerative colitis (UC)

Official title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

132

Start Date

2023-12-04

Completion Date

2026-05

Last Updated

2025-10-03

Healthy Volunteers

No

Interventions

DRUG

Rosnilimab

PD-1 agonist antibody

DRUG

Placebo

Administered via SC

Locations (100)

AnaptysBio Investigational Site 10-115

Phoenix, Arizona, United States

AnaptysBio Investigational Site 10-117

Garden Grove, California, United States

AnaptysBio Investigational Site 10-112

Lancaster, California, United States

AnaptysBio Investigational Site 10-129

Lancaster, California, United States

AnaptysBio Investigational Site 10-108

San Jose, California, United States

AnaptysBio Investigational Site 10-127

Brooksville, Florida, United States

AnaptysBio Investigational Site 10-106

Miami, Florida, United States

AnaptysBio Investigational Site 10-109

Miami Gardens, Florida, United States

AnaptysBio Investigational Site 10-131

Orlando, Florida, United States

AnaptysBio Investigational Site 10-123

Orlando, Florida, United States

AnaptysBio Investigational Site 10-125

Tampa, Florida, United States

AnaptysBio Investigational Site 10-122

Atlanta, Georgia, United States

AnaptysBio Investigational Site 10-124

Oak Lawn, Illinois, United States

AnaptysBio Investigational Site 10-118

Las Vegas, Nevada, United States

AnaptysBio Investigational Site 10-133

Utica, New York, United States

AnaptysBio Investigational Site 10-136

Cincinnati, Ohio, United States

AnaptysBio Investigational Site 10-120

Norman, Oklahoma, United States

AnaptysBio Investigational Site 10-103

Kingsport, Tennessee, United States

AnaptysBio Investigational Site 10-104

Dallas, Texas, United States

AnaptysBio Investigational Site 10-113

Garland, Texas, United States

AnaptysBio Investigational Site 10-135

Georgetown, Texas, United States

AnaptysBio Investigational Site 10-134

Lubbock, Texas, United States

AnaptysBio Investigational Site 10-130

Southlake, Texas, United States

AnaptysBio Investigational Site 10-132

Tyler, Texas, United States

AnaptysBio Investigational Site 10-107

Seattle, Washington, United States

AnaptysBio Investigational Site 12-101

Innsbruck, Austria

AnaptysBio Investigational Site 12-104

Salzburg, Austria

AnaptysBio Investigational Site 12-103

Sankt Pölten, Austria

AnaptysBio Investigational Site 12-102

Vienna, Austria

AnaptysBio Investigational Site 61-102

Sofia, Bulgaria

AnaptysBio Investigational Site 11-102

London, Ontario, Canada

AnaptysBio Investigational Site 11-103

Montreal, Quebec, Canada

AnaptysBio Investigational Site 11-105

Calgary, Canada

AnaptysBio Investigational Site 74-104

Rijeka, Croatia

AnaptysBio Investigational Site 74-101

Zagreb, Croatia

AnaptysBio Investigational Site 16-102

Nantes, France

AnaptysBio Investigational Site 16-103

Nantes, France

AnaptysBio Investigational Site 16-101

Tours, France

AnaptysBio Investigational Site 59-101

Tbilisi, Georgia, Georgia

AnaptysBio Investigational Site 59-106

Tbilisi, Georgia

AnaptysBio Investigational Site 59-103

Tbilisi, Georgia

AnaptysBio Investigational Site 59-102

Tbilisi, Georgia

AnaptysBio Investigational Site 59-104

Tbilisi, Georgia

AnaptysBio Investigational Site 59-105

Tbilisi, Georgia

AnaptysBio Investigational Site 17-107

Berlin, Germany

AnaptysBio Investigational Site 17-106

Brandenburg, Germany

AnaptysBio Investigational Site 17-105

Dachau, Germany

AnaptysBio Investigational Site 17-101

Duisburg, Germany

AnaptysBio Investigational Site 17-110

Erlangen, Germany

AnaptysBio Investigational Site 17-108

Hamburg, Germany

AnaptysBio Investigational Site 17-103

Kiel, Germany

AnaptysBio Investigational Site 17-109

Ulm, Germany

AnaptysBio Investigational Site 20-112

Bologna, Italy

AnaptysBio Investigational Site 20-111

Cagliari, Italy

AnaptysBio Investigational Site 20-110

Catania, Italy

AnaptysBio Investigational Site 20-108

Legnano, Italy

AnaptysBio Investigational Site 20-105

Milan, Italy

AnaptysBio Investigational Site 20-107

Pavia, Italy

AnaptysBio Investigational Site 20-102

Rozzano, Italy

AnaptysBio Investigational Site 20-109

San Donato, Italy

AnaptysBio Investigational Site 20-104

San Giovanni, Italy

AnaptysBio Investigational Site 20-113

Turin, Italy

AnaptysBio Investigational Site 20-106

Udine, Italy

AnaptysBio Investigational Site 21-101

Amsterdam, Netherlands

AnaptysBio Investigational Site 30-108

Bydgoszcz, Poland

AnaptysBio Investigational Site 30-106

Częstochowa, Poland

AnaptysBio Investigational Site 30-112

Elblag, Poland

AnaptysBio Investigational Site 30-102

Katowice, Poland

AnaptysBio Investigational Site 30-115

Katowice, Poland

AnaptysBio Investigational Site 30-111

Krakow, Poland

AnaptysBio Investigational Site 30-123

Krakow, Poland

AnaptysBio Investigational Site 30-103

Lodz, Poland

AnaptysBio Investigational Site 30-119

Lodz, Poland

AnaptysBio Investigational Site 30-114

Lublin, Poland

AnaptysBio Investigational Site 30-104

Poznan, Poland

AnaptysBio Investigational Site 30-117

Poznan, Poland

AnaptysBio Investigational Site 30-120

Poznan, Poland

AnaptysBio Investigational Site 30-116

Rzeszów, Poland

AnaptysBio Investigational Site 30-113

Sopot, Poland

AnaptysBio Investigational Site 30-110

Torun, Poland

AnaptysBio Investigational Site 30-101

Warsaw, Poland

AnaptysBio Investigational Site 30-107

Warsaw, Poland

AnaptysBio Investigational Site 30-109

Warsaw, Poland

AnaptysBio Investigational Site 30-101

Bucharest, Romania

AnaptysBio Investigational Site 31-103

Cluj-Napoca, Romania

AnaptysBio Investigational Site 31-102

Timișoara, Romania

AnaptysBio Investigational Site 58-101

Belgrade, Serbia

AnaptysBio Investigational Site 58-103

Belgrade, Serbia

AnaptysBio Investigational Site 58-104

Belgrade, Serbia

AnaptysBio Investigational Site 58-105

Belgrade, Serbia

AnaptysBio Investigational Site 58-102

Zrenjanin, Serbia

AnaptysBio Investigational Site 24-102

Alicante, Spain

AnaptysBio Investigational Site 24-103

Lleida, Spain

AnaptysBio Investigational Site 27-103

Belfast, United Kingdom

AnaptysBio Investigational Site 27-102

Cambridge, United Kingdom

AnaptysBio Investigational Site 27-106

Liverpool, United Kingdom

AnaptysBio Investigational Site 27-101

London, United Kingdom

AnaptysBio Investigational Site 27-105

Runcorn, United Kingdom

AnaptysBio Investigational Site 27-107

Shrewsbury, United Kingdom

AnaptysBio Investigational Site 27-104

York, United Kingdom